Skip to Main Content


Skip Nav Destination

Abstract 1719: OR2805, an anti-CD163 antibody derived from an elite responder to checkpoint inhibitor therapy relieves immunosuppression caused by tumor associated macrophages

Cancer Res (2021) 81 (13_Supplement): 1719.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Taito Miyamoto
  • Brennah Murphy
  • Nan Zhang
Frontiers in Immunology (2023) 14
Close Modal

or Create an Account

Close Modal
Close Modal